Annabelle M. Belcher, PhD

NCCIH Administrative Supplement (Grant #1R61AT010799; PI: Jessica Magidson [UMCP]) 09/01/20-08/31/22 

Understanding the impact of COVID-19 on methadone treatment retention in an unerserved, minority population with OUD

The goal of this study is to evaluate the impact that COVID-19-related changes to methadone treatment regulations may have on methadone treatment outcomes.

Role: Sub-Award P.I. (20% effort)

The Foundation for Opioid Response Efforts (FORE)  (multi-PI with Eric Weintraub)         4/01/20-03/31/22

Treatment with Buprenorphine through Telemedicine in a Rural Criminal Justice Setting

The goal of this program is to implement new programs of telemedicine-based medications for OUD to three rural detention centers. I led the writing and am the primary outcomes evaluator for this clinical service and research grant.

Role: co-I (15% effort)

R61 1R61AT010799 (PI: Jessica Magidson)                                                          09/01/19-08/31/21      

Peer-Delivered Behavioral Activation Intervention to Improve Adherence to MAT Among Low-Income, Minority Individuals With OUD

The goal of this study is to develop an evidence-based Peer Recovery Coach-delivered treatment model that can be sustainably delivered to improve MAT retention for low-income, minority individuals with OUD.

Role: co-I (5% effort)

NIDA Administrative Supplement (Grant #U01DA038360-05; PI: Eric Wish [UMCP]) 09/01/19-07/31/21 (NCE)

Perceptions of Naloxone in Methadone-Maintained Individuals

The goal of this study is to collect information from current and recent opioid users about their awareness of naloxone and its availability, their attitudes towards naloxone, and its influence on drug use behavior patterns.

Role: Sub-Award P.I. (30% effort)

CareFirst BlueCross/BlueShield (PI: Eric Weintraub)                                                        09/01/18-09/01/20

Expanding Access to Medication-Assisted Treatment in Rural Areas with the Use of Telemedicine

The goal of this program is to increase access for rural populations to medications for OUD with the use of telemedicine. I am the primary outcomes evaluator for this clinical service grant.

Role: co-I (20% effort)

The Foundation for the Science of the Therapeutic Experience (PI: Belcher)                     04/01/17-03/31/20

Open-label dose-extending placebos as an adjunct to methadone treatment: A pilot study

The goal of this study is to determine whether conditioned placebo effects can be harnessed to decrease methadone dose escalation in opioid use disorder-diagnosed individuals undergoing medication-based treatment.

Role: PI

MPowering the State: Strategic Partnership funds (co-PI with Eric Wish [UMCP])           07/01/17-06/30/20

Novel Therapies to Reduce Opioid Use

The goal of this study is to employ comprehensive urine toxicology screens that include information on biological content levels of a wide range of opioids to examine drug use patterns in opioid use disorder-diagnosed methadone-treated individuals.

Role: co-PI with Eric Wish, UMCP

2002                Guest lecturer, “Empowering the Community” Conference, University of California, Irvine

2003-2008       Annual Lecturer, Brain Awareness Week, University of California, Irvine

2004                Lecturer, “The Danger of Trying Drugs Just Once”-- Presentation given to juvenile offenders at Joplin Youth Center, a non-secure residential treatment center for boys in Orange County, CA

2008, 2009       Referee, SDGE/Graduate Women in Science Fellowship

2009                Panel Representative, Community College Day, NIH, Bethesda, MD

2011                Lecturer, “Science for Non-Scientists” series, NIDA, Baltimore, MD

2012                Career Day presentation, Patterson Park Public Charter School, Baltimore, MD

2013                Scientist demonstrator, “Take Your Kid to Work Day” at NIDA-IRP

2015                Judge for the annual Greater Baltimore Society for Neuroscience Meeting

2017                Mentor to a Baltimore city middle school-aged child, Paul’s Place 

https://ndews.umd.edu/feature/naloxone-opioid-user-knowledge-attitudes-behaviors-practices-three-cities

2000-2001       Graduate Teaching Assistant, Neurobiology (BIO110L), University of California, Irvine

2001-2003       Course Instructor, Neurobiology lecture/lab course (BIO113L), University of California, Irvine

2004-2005       Research Mentor for undergraduate neurobiology major, UC Irvine Undergraduate Research Program

2008                Course Instructor, COSMOS, COSMOS-University of California, Irvine

2009                Course Instructor, Law and Neuroscience (Psychology 594LN), University of California, Santa Barbara

2010-2012       Research Mentor for the NIDA Summer Student Programs

2011-2012       Course Instructor, Introduction to Addiction Science, Neuroimaging Research Branch, NIDA-IRP

2011-2014       Research Mentor, NIDA post-baccalaureate IRTA Fellow

2016                GPLS 775 “The Interface of Pain, Addiction and Affect” Course Lecturer

2018                Lecturer, UMB Spring 2018 Mini-Course in Addiction (coursemaster: Mary Kay Lobo)

2018, 2019       Lecturer, Responsible Conduct of Research course on Collaboration